It is based on impairing the energy metabolism of tumor cells by inhibiting enzymes in the glycolysis, HK-II, glyceraldehyde 3-phosphate dehydrogenase, phosphoglycerate kinase, and oxidative phosphorylation, succinate dehydrogenase (168). This evidence concerns the gene HK2 and neoplasm.